Les problèmes actuels du contrôle antidopage équin

Bonnaire, 1998, Studies of the structures of extractive and recombinant growth hormone from different species by mass spectrometry Bonnaire, 1995, Peptides et dopage : un nouveau challenge pour les laboratoires, Sci. Sports, 10, 83, 10.1016/0765-1597(96)89531-1 Bonnaire, 1992, GC/MS/NICI method for natural and synthetic corticosteroid detection in equine urine, Administration of dexamethasone and synacthen Gareau, 1996, Erythropoietin abuse in athletes, Nature, 380, 113, 10.1038/380113a0 Kicman, 1997, Serum IGF-1 and IGF binding proteins 2 and 3 as potential markers of doping with human growth hormone, Clin. Endocrinol., 47, 43, 10.1046/j.1365-2265.1997.2111036.x Laidler, 1994, New decision limits and quality control material for detecting human chorionic gonadotrophin misuse in sports, Clin. Chem., 40, 1306, 10.1093/clinchem/40.7.1306 Scippo, 1997, Identification des vaches laitières traitées à la somatotropine bovine, Ann. Med. Vet., 141, 381 Souillard, 1996, Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses, Biopharm. Drug Dispos., 17, 805, 10.1002/(SICI)1099-081X(199612)17:9<805::AID-BDD995>3.0.CO;2-H Thompson, 1992, Growth hormone in mares and stallions: Pulsatile secretion response to growth hormone-releasing hormone, and effects of exercise, sexual stimulation and pharmacological agents, J. Anim. Sci., 70, 1201, 10.2527/1992.7041201x